Stay updated with breaking news from Facilitate phase. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Science 37 s Metasite to Facilitate Phase 3 Study Enrollment byExpanding Access and Maximizing Convenience for PatientsRESEARCH TRIANGLE PARK, N.C., July 11, 2023 Science 37 Holdings, Inc.. ....
Moleculin Reports First Quarter 2021 Financial Results and Provides Programs Update - Multiple ongoing clinical studies expected to drive key clinical and regulatory milestones throughout next 18 months - - Significantly strengthened financial position extends cash runway through 2023 - News provided by Share this article HOUSTON, May 12, 2021 /PRNewswire/ Moleculin Biotech, Inc., (Nasdaq: MBRX) (Moleculin or the Company), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors and viruses, today announced its financial results for the quarter ended March 31, 2021. The Company also provided an update on its portfolio of oncology drug candidates for the treatment of highly resistant tumors and viruses. ....